Skip to main content

Table 1 Anthropometric characteristics and respiratory function data of COPD patients and control subjects

From: Absence of human rhinovirus and respiratory syncytial virus from bronchoalveolar lavage and bronchial biopsies of selected patients with stable chronic obstructive pulmonary disease

Parameters

COPD

Controls

(n = 31)

(n = 22)

Gender, Males (%)

26 (83,8 %)

16 (72,7 %)

Age, years

67.6 ± 8.1

62.4 ± 11.7

BMI, kg/m2

25.3 ± 4.6**

25.7 ± 4.5

Pack/Years

57 ± 27*

35.45 ± 35

FVC, % pred

85.6 ± 20.1

93.6 ± 15.9

FEV1, % pred

70.8 ± 18.6***

93.3 ± 15.9

FEV1/FVC, %

63.7 ± 8.04***

78.9 ± 5.28

Spirometric classification of COPD: I, II, III, IV

11,11,9,0

NA

PEF, % pred

69.4 ± 20*

87 ± 23

DLCO, % pred

72.1 ± 25.5

85 ± 22.8

SpO2, %

94.7 ± 3.2*

96.45 ± 1.2

PaO2, mmHg

70.2 ± 12.1*

79.57 ± 6.47

PaCO2, mmHg

38 ± 2.25

40.1 ± 1.7

mMRC scale (0,1,2,3,4)

1.09 ± 1** (10,13,5,1,2)

0.36 ± 0.72 (16,5,0,1,0)

Symptom/risk evaluation of COPD: A, B, C, D

19,3,4,5

NA

BODE index (0-2,3-4,5-6,7-10)

1.96 ± 2.37** (23,4,2,2)

0.4 ± 0.73 (21,1,0,0)

Inhaled steroids, n (%)

4(7.5 %)

0(0)

  1. Values are means (±SD)
  2. Abbreviations: BMI body mass index; FVC forced vital capacity; FEV 1 forced expiratory volume in one second; NA Non Applicable; PEF peak expiratory flow; DL CO diffusing capacity of the lung for carbon monoxide; SpO 2 % arterial oxygen saturation measured with pulse arterial oximeter; PaO 2 partial arterial oxygen tension (at room air); PaCO 2 partial arterial carbon dioxide tension; mMRC modified Medical Research Council scale (0: not troubled by breathlessness except on strenuous exercise, 1: shortness of breath when hurrying on the level or walking up a slight hill, 2: walks slower than people of the same age on the level because of breathlessness or has to stop for breath when walking at own pace on the level, 3: stops for breath after walking about 100 m or after a few minutes on the level, 4: too breathless to leave the house or breathless when dressing or undressing); Symptom/risk COPD evaluation: A = Low risk-Less symptoms/B = Low risk-More symptoms/C = High risk-Less symptoms/D = High risk-More symptoms; BODE index: Body mass index (kg/m2), airflow Obstruction (FEV1% pred), Dyspnea (mMRC scale), Exercise (6 min walking distance) (0–2 points: 80 % 4 year survival, 3–4: 67 %, 5–6: 57 %, 7–10: 18 %)
  3. *p < 0.05 compared with controls; **p < 0.01 compared with controls; ***p < 0.001 compared with controls
Back to article page